Clinical observation of lymphopenia in patients with newly diagnosed glioblastoma.

Woo Jin KimYun-Sik DhoChan-Young OckJin Wook KimSeung Hong ChoiSoon-Tae LeeIl Han KimTae Min KimChul-Kee Park

Published in: Journal of neuro-oncology (2019)

Lymphopenia is a frequent event during GBM disease progression and treatment. Treatment-related lymphopenia is profound and prolonged and can be used as a prognostic factor for GBM patients.

Keyphrases

newly diagnosed
prognostic factors
end stage renal disease
ejection fraction
chronic kidney disease
combination therapy
autism spectrum disorder
replacement therapy
drug induced